FDA fast tracks ocular melanoma treatment

A new class of treatment that can selectively destroy cancer cells using a light-activated viral nanoparticle has received FDA fast track designation for the treatment of ocular melanoma.

Read the full story

Posted in Melanoma In The News, FDA, Information

FDA grants fast track designation to ImmunoPulse IL-12 for melanoma

The FDA granted fast track designation to ImmunoPulse IL-12 for the treatment of metastatic melanoma that progressed during therapy with pembrolizumab or nivolumab.

Read the full story

Posted in Melanoma In The News, FDA

FDA accepts new drug application for binimetinib for advanced NRAS-mutant melanoma

The FDA has accepted Array BioPharma’s new drug application for binimetinib for treating patients with NRAS-mutant melanoma, according to a press release from the company.

Read the full story

Posted in Melanoma In The News, FDA

FDA Approvals, New Biopsy Techniques Advance Head and Neck Melanoma Care

Advancements in biopsy techniques, as well as several recently approved new therapeutic agents, have made a significant difference in outcomes for patients with melanoma of the head and neck, says Carol Rossier Bradford, MD, a head and neck surgeon and professor of Otolaryngology at the University of Michigan Health System.

Read the full story

Posted in FDA, Cancer in the News

Melanoma Google Alerts

Melanoma Google Alerts is a summary of daily articles found in print and on the internet. The articles do not necessarily represent the views of Melbourne Melanoma Project

News Archives

News Categories